SCHEMBL24422249

SCHEMBL24422249

c1ccc(N(c2ccc(C34CC5CC(CC(C5)C3)C4)cc2)c2cccc(N(c3ccccc3)c3ccc4c(c3)oc3ccccc34)c2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.35
▸ ALDH1A1 P00352 4/20 0.35
▸ AHR P35869 2/20 0.35
▸ MAPT P10636 5/20 0.34
▸ MEN1 O00255 5/20 0.34
▸ KMT2A Q03164 5/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ GAA P10253 3/20 0.33
▸ HTT P42858 2/20 0.33
▸ NPSR1 Q6W5P4 2/20 0.33
▸ POLB P06746 1/20 0.33
▸ GFER P55789 1/20 0.33
▸ STS P08842 3/20 0.33
▸ EPHX2 P34913 2/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ GRIN2D O15399 1/20 0.32
▸ GRIN3B O60391 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22815485 0.96 LMNA (0.33) LMNAALDH1A1AHRMAPTMEN1
SCHEMBL23691293 0.95 ALDH1A1 (0.39) LMNAALDH1A1AHRMAPTMEN1
SCHEMBL22815519 0.94 LMNA (0.40) LMNAALDH1A1MAPTMEN1KMT2A
SCHEMBL24421871 0.93 LMNA (0.39) LMNAALDH1A1AHRMAPTMEN1
SCHEMBL22815314 0.92 MMP12 (0.32) LMNAALDH1A1AHRMAPTMEN1
SCHEMBL24421997 0.92 LMNA (0.36) LMNAALDH1A1AHRMAPTMEN1
SCHEMBL26360688 0.92 LMNA (0.36) LMNAALDH1A1AHRMAPTMEN1
SCHEMBL21038181 0.91 AHR (0.36) LMNAALDH1A1AHRMAPTMEN1
SCHEMBL24421890 0.90 ALDH1A1 (0.37) LMNAALDH1A1AHRMAPTMEN1
SCHEMBL26361181 0.89 LMNA (0.36) LMNAALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11778901-B2 Organic electroluminescent material and organic electroluminescent device comprising same SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-03 — — US disclosed
US-11778901-B2 Organic electroluminescent material and organic electroluminescent device comprising same SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-03 — — US disclosed
US-20220149278-A1 ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2022-05-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11778901-B2 Organic electroluminescent material and organic electroluminescent device comprising same MAOA, AOC1, AOC2 LMNA 1877/4885ALDH1A1 67/4885AHR 1588/4885
US-20220149278-A1 ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME MAOA, AOC1, AOC2 LMNA 1863/4885ALDH1A1 65/4885AHR 1571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback